PROCEPT BioRobotics (PRCT) Total Liabilities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Total Liabilities data on file, last reported at $139.4 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 7.05% year-over-year to $139.4 million in Q1 2026; TTM through Mar 2026 was $139.4 million, a 7.05% increase from a year earlier, with the FY2025 full-year figure at $142.2 million, up 7.9% from the prior year.
• Total Liabilities for Q1 2026 stood at $139.4 million, down from $142.2 million in the prior quarter.
• Over the last five years, Total Liabilities for PRCT reached as high as $142.2 million in Q4 2025 and fell as low as $68.2 million in Q1 2022.
• Historically, Total Liabilities has averaged $118.0 million across 5 years, with a median of $122.6 million in 2024.
• Across the five-year window, Total Liabilities jumped 63.33% in 2023 and declined 1.25% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $112.3 million in 2022, then increased by 10.43% to $124.0 million in 2023, then rose by 6.32% to $131.8 million in 2024, then climbed by 7.9% to $142.2 million in 2025, then slipped by 1.98% to $139.4 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $139.4 million in Q1 2026, $142.2 million in Q4 2025, and $131.3 million in Q3 2025.